Abstract:CRISPR-based diagnostics (CRISPR/Dx) have revolutionized the field of molecular diagnostics. It enables home self-test, field-deployable, and point-of-care testing (POCT). Despite the great potential of CRISPR/Dx in diagnoses of biologically complex diseases, preamplification of the template often is required for the sensitive detection of low-abundance nucleic acids. Various amplification-free CRISPR/Dx systems were recently developed to enhance signal detection at sufficient sensitivity. Broadly, these amplification-free CRISPR/Dx systems are classified into five groups depending on the signal enhancement strategies employed: CRISPR/Cas12a and/or CRISPR/Cas13a are integrated with: (1) other catalytic enzymes (Cas14a, Csm6, Argonaute, duplex-specific nuclease, nanozyme, or T7 exonuclease), (2) rational-designed oligonucleotides (multivalent aptamer, tetrahedral DNA framework, RNA G-quadruplexes, DNA roller machine, switchable-caged guide RNA, hybrid locked RNA/DNA probe, hybridized cascade probe, or "U" rich stem-loop RNA), (3) nanomaterials (nanophotonic structure, gold nanoparticle, micromotor, or microbeads), (4) electrochemical and piezoelectric plate biosensors (SERS nanoprobes, graphene field-effect transistor, redox probe, or primer exchange reaction), or (5) cutting-edge detection technology platforms (digital bioanalysis, droplet microfluidic, smartphone camera, or single nanoparticle counting). Herein, we critically discuss the advances, pitfalls and future perspectives for these amplification-free CRISPR/Dx systems in nucleic acids detection. The continued refinement of these CRISPR/Dx systems will pave the road for rapid, cost-effective, ultrasensitive, and ultraspecific on-site detection without resorting to target amplification, with the ultimate goal of establishing CRISPR/Dx as the paragon of diagnostics.

The Hybridization Chain Reaction in the Development of Ultrasensitive Nucleic Acid Assays

Advances in Amplification-Free Detection of Nucleic Acid: CRISPR/Cas System As a Powerful Tool.

Application of Hybridization Chain Reaction (HCR) in Electrochemical Analysis

Recent progress in the development of DNA-based biosensors integrated with hybridization chain reaction or catalytic hairpin assembly

Applications of hybridization chain reaction optical detection incorporating nanomaterials: A review

Electrochemical Biosensors Employing Hybridization Chain Reaction: From Structural Design to Applications

Mimicking an environment for enzyme-free paper-based nucleic acid tests at the point of care

Hybridization chain reaction-based DNA nanomaterials for biosensing, bioimaging and therapeutics

Mimicking a Cellular Crowding Environment for Enzyme-Free Paper-Based Nucleic Acid Tests at the Point of Care

Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA

Label-free, Background-Free Detection of Nucleic Acid with Immobilization-Free Heterogeneous Biosensor and One-Pot Hybridization Chain Reaction Amplification

Amplification-free nucleic acids detection with next-generation CRISPR/dx systems

Hybridization Chain Reaction-Based Electrochemical Biosensors by Integrating the Advantages of Homogeneous Reaction and Heterogeneous Detection

Designing a Hybrid Chain Reaction Probe for Multiplex Transcripts Assay with High-Level Imaging

Hybridization chain reaction-based instantaneous derivatization technology for chemiluminescence detection of specific DNA sequences.

Microfluidic DNA Hybridization Assays

Molecular Mechanisms Underlying CRISPR/Cas-Based Assays for Nucleic Acid Detection

Signal Amplification for Nanobiosensing

A CRISPR–Cas9-triggered strand displacement amplification method for ultrasensitive DNA detection

Hybridization Chain Reaction-Amplified Electrochemical DNA-Based Sensors Enable Calibration-Free Measurements of Nucleic Acids Directly in Whole Blood

Recent advances in cascade isothermal amplification techniques for ultra-sensitive nucleic acid detection